Neuropace Inc (NPCE)
Healthcare
Medical Devices
—
12.90 $
-6.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Neuropace Inc (NPCE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -5.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.4 | -2.3 | -3.3 | -7.5 | -3.9 | -1.7 | -4.8 | -7.5 | -2.1 | -1.9 | 0.5 | -5.9 | -9.4 | |
| 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 2.0 | |
| 2.7 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 3.2 | 2.6 | 2.6 | 2.3 | 11 | |
| 3.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.8 | 1.2 | -0.8 | -2.6 | -0.4 | 0.5 | -3.0 | -4.4 | 2.1 | -1.7 | -0.1 | -2.4 | -2.0 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.1 | 0.4 | |
| 5.3 | 4.2 | 3.5 | 2.4 | 3.2 | 1.4 | 2.0 | 0.0 | -0.2 | 0.0 | -0.1 | -0.1 | -0.4 | |
| 0.0 | 0.0 | 0.0 | -0.6 | -0.1 | -0.1 | -0.1 | -50 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | – | -0.1 | 0.0 | – | – | |
| 0.2 | 0.0 | 8.2 | 0.1 | 0.5 | 2.9 | 0.8 | 21 | -1.9 | -0.2 | 0.6 | -0.2 | -1.7 | |
| 1.1 | 1.9 | 8.3 | -5.1 | -0.2 | 2.6 | -2.0 | 14 | -4.2 | -2.2 | 1.0 | -6.9 | -12 | |
| -4.4 | -2.3 | -3.4 | -7.6 | -4.0 | -1.8 | -4.8 | -7.5 | -2.3 | -2.0 | 0.4 | -6.0 | -9.8 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.